Concepedia

Yuming Wei

YW

Statistics

Publications

6

Citations

148

H-Index

6

Active since

2015

Affiliations

Chinese University of Hong Kong(Current)

Sun Yat-sen University

Sun Yat-sen University Cancer Center

Yuming Wei is an author at Chinese University of Hong Kong specializing in medicine, pharmacology, and cancer pharmacology.

ORCID

Publications per year

2015–2018

6

Publications

6

Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia

Kenneth K.W. To, Daniel C. Poon, Yuming Wei et al. · Biochemical Pharmacology · 2015 · 50 citations

, , +10

Pelitinib (<scp>EKB</scp>‐569) targets the up‐regulation of <scp>ABCB</scp>1 and <scp>ABCG</scp>2 induced by hyperthermia to eradicate lung cancer

Kenneth K.W. To, Daniel C. Poon, Yuming Wei et al. · British Journal of Pharmacology · 2015 · 40 citations · Full text

, , +17

Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cells

Yuming Wei, Kenneth K.W. To, Steve C. F. Au‐Yeung · Journal of Pharmacological Sciences · 2015 · 23 citations · Full text

, , +17

A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases

Qian Zhang, Mengbi Yang, Kasper K. Sørensen et al. · Scientific Reports · 2017 · 14 citations · Full text

, , +17

AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models

Huiling Hong, Alex Chun Koon, Zhefan Stephen Chen et al. · Journal of Biological Chemistry · 2018 · 11 citations · Full text

, , +13

1–5 of 6